Ronald van der Geest

Ronald van der Geest is a highly experienced professional in the pharmaceutical and life sciences industry, serving as Managing Partner and Co-Founder of 3D-PharmXchange since March 2010, where strategic and operational support is provided. Ronald also holds the position of Chief Development Officer and Founder at Onicor, focusing on innovative treatments for onychomycosis, and has been a Chief Development Officer at Treeway since August 2013, leading breakthrough therapies for ALS and Alzheimer's disease. Prior roles include Chief Development Officer at Protinhi Therapeutics, with a focus on drug development for dengue and zika viruses, and various leadership positions at Kinesis Pharma BV, InPEC BV, and Tibotec/Janssen, where drug development and project management were central. Ronald's extensive background in clinical pharmacology began with a PhD in Biopharmaceutical Sciences from Leiden University, complemented by early scientific research on drug delivery systems for Parkinson's Disease.